Double-blind trial comparing labetalol with atenolol in the treatment of systemic hypertension with angina pectoris
- 1 September 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 56 (8) , 551-554
- https://doi.org/10.1016/0002-9149(85)91183-x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- ROLE OF HEART RATE IN PATHOPHYSIOLOGY OF CHRONIC STABLE ANGINAThe Lancet, 1984
- LabetalolArchives of internal medicine (1960), 1983
- Comparative effects of abrupt withdrawal of propranolol and verapamil in angina pectorisThe American Journal of Cardiology, 1982
- Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectorisThe American Journal of Cardiology, 1982
- Alternatives to beta‐blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.British Journal of Clinical Pharmacology, 1982
- Clinical evaluation of atenolol in hypertensive patients.Circulation, 1981
- Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectorisAmerican Heart Journal, 1981
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 11. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experienceAmerican Heart Journal, 1980
- Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.Published by Wiley ,1979
- CORONARY VASOSPASM IN ANGINA PECTORISThe Lancet, 1977